Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou've got your Wegovy pen in hand, you're looking at the dial, and you're not entirely sure whether a "click" equals a dose or part of one. Here's the short answer: on the Wegovy pre-filled injection pen, each full dose is set by dialling to the correct dose window, not by counting audible clicks — the clicks are a mechanical feature of the pen mechanism, not a measure of how much medicine you're injecting. Your prescriber sets the dose; the pen delivers it. These are prescription-only medicines, and the dosing schedule is agreed during your clinical assessment — so the detail below is here to help you understand your device, not to replace the guidance your prescriber has given you. The NHS semaglutide page and your Patient Information Leaflet are the definitive sources for how to use your pen safely.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A lot of people finishing their first injection pull the pen away wondering whether it worked. They counted the clicks, found no consistent number across injections, and started worrying. That concern is understandable. The audible and tactile clicks from a Wegovy pen come from the drive mechanism inside the device as the plunger advances, not from a click-per-unit counting system the way some insulin pens work. The number of clicks you hear can vary depending on how firmly you hold the pen against your skin, the injection angle, and the natural variation in the spring mechanism. None of that variation changes how much semaglutide has been delivered.
What actually determines your dose is the dose window: the small clear window on the side of the pen body where a number appears when you turn the dose dial. That number (0.25, 0.5, 1.0, 1.7 or 2.4 (or 7.2 on the newer pen)) is the dose in milligrams your prescriber has set for this stage of your treatment. Confirm that number before every injection. If the window shows the right dose and you held the pen in place for the full count your leaflet specifies, the injection is complete. The clicks are reassuring confirmation that the mechanism is moving, but they are not a measurement.
If you want a clear reference for the full titration sequence and what each stage looks like on the pen, the Wegovy click dosage chart sets it out step by step.
Wegovy's titration schedule exists for a specific reason: semaglutide's most common side effects are gastrointestinal, and starting at the maintenance dose would, for most people, produce significant nausea. The 0.25 mg starting dose is a settling-in period, your gut is adjusting to the medicine, not yet receiving a therapeutic weight-management dose. Most people notice relatively little appetite change at 0.25 mg, which occasionally makes them think the medicine isn't working. It is working; it's just doing the tolerability job first.
From there, the schedule typically moves to 0.5 mg, then 1.0 mg, then 1.7 mg, with each step around four weeks apart, before reaching the 2.4 mg maintenance dose. Your prescriber may extend time at any step if side effects need more time to settle. In April 2026 the MHRA approved a dedicated single-dose 7.2 mg pen for adults with a BMI of 30 or above, following trial evidence reporting around 20.7% average weight loss over 72 weeks, though that dose is the maximum, not a starting point, and only your prescriber can determine whether it is suitable for you.
Skipping steps or dialling to a higher dose window than prescribed is not safe and, in practice, will likely intensify nausea without meaningfully improving outcomes. If you think your current dose is no longer producing results, that conversation belongs with your prescriber, not with the dial. Details on the full dose range are covered on the Wegovy doses page.
The practical sequence matters. Before you inject, check the dose window shows the number your prescriber has confirmed for this stage. Inspect the liquid, it should be clear and colourless; do not use it if it looks cloudy or contains particles. Attach a new needle, prime if indicated in your leaflet, choose your injection site (abdomen, thigh or upper arm, rotated each week), and press the pen firmly against the skin. Hold the button down and keep the pen pressed in place until the dose window shows zero and a few more seconds have passed, your leaflet gives the exact count. Only then withdraw.
The relationship between clicks and dosage in Wegovy pens is a question our prescribers hear regularly, and the short version is always the same: trust the window, not the sound. If the window returns to zero and the injection site looks undisturbed, the dose has been given. If the window didn't reach zero, contact your prescriber or pharmacist before deciding what to do, do not simply inject again.
For most people, once they have done two or three injections the pen feels straightforward. The Wegovy dosage overview covers the broader schedule context, and the NHS semaglutide guidance includes practical how-to-inject notes alongside the safety information. Your Patient Information Leaflet, which came in the box, remains the primary reference for your specific pen format.
There are a handful of situations where reaching out promptly is the right move. If you are unsure whether an injection delivered fully, do not guess, call your pharmacy or prescriber the same day. If you have been on your current dose for the agreed period and your prescriber has not yet reviewed you for the next step, get in touch rather than adjusting yourself. And if side effects at your current dose are making weekly injections very difficult, that is exactly the conversation your prescriber needs to have with you, staying at a lower dose for longer is a legitimate clinical choice, and there is no fixed timetable that overrides your individual response.
Wegovy is a prescription-only medicine for a reason: the clinical assessment, the dose decisions and the ongoing reviews are the parts that make treatment safe and effective. If you have questions about whether your current dose is right or what the next step looks like, the team at nume (a GPhC-registered pharmacy with a clinical prescriber reviewing every consultation) is available seven days a week for aftercare support. Equally, if you are still exploring whether Wegovy is appropriate for your situation, the weight-loss treatment overview gives a grounded starting point. Cost and how private treatment is priced are covered on our Wegovy treatment page if that is useful context.
Speak to our prescribers if you have questions about your dose, your pen, or where you are in the titration schedule.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.